Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy

Europace

Volumn 10, Issue 3, 2008, Pages 374-378

  Burri, Haran ^a   Sunthorn, Henri ^a   Somsen, Aernout ^b   Fleury, Eric ^a   Stettler, Carine ^a   Shah, Dipen ^a   Righetti, Alberto ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Department of Cardiology ^*  (Netherlands)

Author keywords

Cardiac resynchronization therapy; MIBG; Nervous system; Sympathetic; Ventricular function

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADRENERGIC SYSTEM; AGED; ANGIOGRAPHY; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART NERVE; HEART SCINTISCANNING; HUMAN; MALE; NERVE CONDUCTION; PRIORITY JOURNAL;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RADIONUCLIDE ANGIOGRAPHY; RADIONUCLIDE IMAGING; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 44649107067     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun017     Document Type: Article

References (19)

1. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003;108:266-9.
2. Alonso C, Ritter P, Leclercq C, Mabo P, Bailleul C, Daubert JC. Effects of cardiac resynchronization therapy on heart rate variability in patients with chronic systolic heart failure and intraventricular conduction delay. Am J Cardiol 2003;91:1144-7.
3. Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 2005;46:1875-82.
4. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 2003;289:2685-94.
5. Hamdan MH, Barbera S, Kowal RC, Page RL, Ramaswamy K, Joglar JA et al. Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2002;89:1047-51.
6. Najem B, Unger P, Preumont N, Jansens JL, Houssiere A, Pathak A et al. Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol 2006;291:H2647-52.
7. Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A et al. Comparison of the prognostic value of cardiac iodine-123 meta-iodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol 2003;41:231-8.
8. Kioka H, Yamada T, Mine T, Morita T, Tsukamoto Y, Tamaki S et al. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging in patients with mild to moderate chronic heart failure. Heart 2007;93:1213-8.
9. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Longer-termeffects of cardiac resynchronization therapy onmortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase. Eur Heart J 2006;27:1928-32.
10. Burri H, Sunthorn H, Shah D, Lerch R. Optimization of device programming for cardiac resynchronization therapy. Pacing Clin Electrophysiol 2006;29:1416-25.
11. Burri H, Sunthorn H, Somsen A, Zaza S, Fleury E, Shah D et al. Optimizing sequential biventricular pacing using radionuclide ventriculography. Heart Rhythm 2005;2:960-5.
12. Ohshima S, Isobe S, Izawa H, Nanasato M, Ando A, Yamada A et al. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients. J Am Coll Cardiol 2005;46:2061-8.
13. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87:VI17-VI23.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
15. 99mTc-tetrofosmin electrocardiographically gated SPECT. J Nucl Med 2001;42:1017-24.
16. Erol-Yilmaz A, Verbene HJ, Schrama TA, Hrudova J, De Winter RJ, Van Eck-Smit BLF et al. Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin Electro 2005;28:304-10.
17. Bleeker GB, Bax JJ, Fung JW-H, van der Wall EE, Zhang Q, Schalij MJ et al. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 2006;97:260-3.
18. Gould PA, Kong G, Kalff V, Duffy SJ, Taylor AJ, Kelly MJ et al. Improvement in cardiac adrenergic function post biventricular pacing for heart failure. Europace 2007;9:751-6.
19. Somsen GA, Borm JJ, de Milliano PA, van Vlies B, Dubois EA, van Royen EA. Quantitation of myocardial iodine-123 MIBG uptake in SPECT studies: a new approach using the left ventricular cavity and a blood sample as a reference. Eur J Nucl Med 1995;1149-54.